Market Tracker

02/05 5:16pm ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

86.61
Delayed Data
As of Feb 05
 -5.11 / -5.57%
Today’s Change
81.98
Today|||52-Week Range
143.45
-31.17%
Year-to-Date

Today’s Trading

Previous close91.72
Today’s open89.78
Day’s range84.54 - 92.23
Volume4,571,268
Average volume (3 months)2,211,788
Market cap$22.5B
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-58.59%
Earnings growth (this year)+33.00%
Earnings growth (next 5 years)+53.55%
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales48.16
Price/Book20.63

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC-0.23-0.16%
ZTSZoetis Inc-0.63-1.52%
MYLMylan NV-0.92-1.76%
INCYIncyte Corp-1.03-1.43%
Data as of 4:02pm ET, 02/05/2016

Financials

Next reporting dateMay 3, 2016
EPS forecast (this quarter)$0.13
Annual revenue (last year)$580.4M
Annual profit (last year)-$738.6M
Net profit margin-127.09%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts